HEART FAILURE WITH REDUCED EJECTION FRACTION

This study tests a new drug called JK07 in 282 adults aged 18-85 with chronic heart failure. The goal is to see if JK07 can safely improve heart function. Participants are divided into two groups based on their heart's pumping ability. The study is double-blind, meaning neither p…

This study tests whether a special ketone drink can help people with heart failure feel less tired and short of breath during exercise. About 25 adults with stable heart failure and reduced pumping function will drink the ketone drink and then have their exercise ability and hear…

This study looks at whether sending cardiologists quarterly emails about their prescribing habits can help more patients get the right medications for heart failure and atrial fibrillation. About 7,000 patients will be included. The goal is to see if this simple feedback strategy…

This study looks at 500 adults in Romania with heart failure who are taking Entresto. Researchers want to see if patients are also getting other recommended heart medications. The goal is to understand real-world treatment patterns and how well they follow official guidelines.

This study uses healthcare claims data from over 23,000 people with heart failure and type 2 diabetes to see if the drug empagliflozin works as well in everyday practice as it did in a major clinical trial. Researchers compare empagliflozin to another diabetes drug, sitagliptin, …

This study looks at tiny pieces of RNA in the blood of 200 adults hospitalized with acute congestive heart failure. Researchers want to see if these RNA levels change as patients receive treatment to remove excess fluid, and whether they can help predict who will improve. The goa…